Tecan Group AG

Tecan Group AG is a Swiss-based company specializing in the development, production, and distribution of advanced automation and detection solutions for life science laboratories. Founded in 1980, the company's mission is to improve people's lives and health by empowering customers to scale healthcare innovation globally, from life science research to clinical applications. Its global headquarters are located in Männedorf, canton of Zürich, Switzerland.

Tecan's comprehensive product portfolio includes liquid handling and automation systems, microplate readers and washers, consumables, Next-Generation Sequencing (NGS) reagents, immunoassays, antibodies, and specialized software. The company operates through two primary segments: the Life Sciences Business, which provides automated workflow solutions directly to end-users, and the Partnering Business, which develops and manufactures OEM instruments and components for distribution by partner companies. Key offerings in the Partnering Business include Cavro OEM components, SYNERGENCE customized OEM systems, and PARAMIT contract design and manufacturing services.

In recent leadership changes, Monica Manotas was appointed CEO effective August 1, 2025, and Camila Japur joined as Chief Financial Officer on March 30, 2026. Tecan continues to reinforce its market position as a pioneer and global leader in laboratory automation, with recent initiatives including a collaboration with NVIDIA to create Data-Driven Labs, announced in March 2026. The company's Annual General Meeting in April 2026 saw shareholders endorse a stable dividend, reflecting ongoing financial stability.